Experience of Administering Oral Prostaglandin E1 for Failed Back Surgery Syndrome: A case report.
10.3344/kjp.2006.19.1.101
- Author:
Hae Kwang LEE
1
;
Seung Hoon WOO
;
Woo Yong LEE
Author Information
1. Pain Clinic and Department of Anesthesiology, Sanggye Paik Hospital, College of Medicine, Inje University, Seoul, Korea. roma56@sanggyepaik.ac.kr
- Publication Type:Case Report
- Keywords:
failed back surgery syndrome;
lumbosacral symptoms;
prostaglandin E1;
radiculopathy;
spinal stenosis
- MeSH:
Alprostadil*;
Catheterization;
Catheters;
Cauda Equina;
Failed Back Surgery Syndrome*;
Female;
Fractures, Compression;
Humans;
Leg;
Middle Aged;
Muscle Weakness;
Radiculopathy;
Spinal Stenosis;
Vascular Diseases;
Vasodilation
- From:The Korean Journal of Pain
2006;19(1):101-103
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Oral prostaglandin E1 (PGE1) is a medicine that is clinically applied during a treatment of patients suffering with vascular disease with chronic arterial obstruction because it has vasodilation and anti-platelet effects. The mechanisms of lumbosacral symptoms associated with spinal stenosis probably include vascular insufficiency with hypoxic injury to the cauda equina and the nerve roots. Thus, increasing the blood supply would be beneficial to improve the pathophysiologic condition. Several studies on the improvement of clinical symptoms of spinal stenosis by PGE1 treatment have been reported on. In this case, 47-year old female underwent posterior compression and posterolateral fusion with a cage at L2-4 due to L3 compression fracture, and she did not show improvement of the radiating pain of her right leg after the operation. Therefore, she received repetitive epidural catheterization and adhesiolysis, epidural block and physical therapy, but her symptoms deteriorated after temporary improvement. Finally, she was given PGE1 and the radiculopathy was completely improved, although some muscle weakness still remained.
